ELANCO ANIMAL HEALTH INC (5EA.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:5EA - US28414H1032 - Common Stock
18.358 EUR
+18.36 (+Infinity%)
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.65B | 4.76B | 3.27B | 3.07B | 3.07B | |||
| Cost Of Goods | 2.01B | 2.13B | 1.67B | 1.47B | 1.57B | |||
| Gross Profit | 2.64B | 2.63B | 1.61B | 1.60B | 1.49B | |||
| Operating Expenses | 2.23B | 2.33B | 1.68B | 1.23B | 1.18B | |||
| Research and Development | 349.00M | 369.00M | 327.00M | 270.10M | 246.60M | |||
| Selling, General, and Administrative Expenses | 1.33B | 1.40B | 996.60M | 760.20M | 735.20M | |||
| Operating Income | 406.00M | 302.00M | -76.80M | 370.00M | 313.80M | |||
| Interest Income/Expense | -234.00M | -236.00M | -149.80M | -78.90M | -29.60M | |||
| Other Income/Expense | -17.00M | -5.00M | 132.70M | -27.40M | -41.30M | |||
| Non Recurring Items | -353.00M | -628.00M | -627.50M | -185.50M | -129.60M | |||
| Income Before Taxes | -198.00M | -567.00M | -672.00M | 78.20M | 114.10M | |||
| Income Tax | -23.00M | -95.00M | -111.90M | 10.30M | 27.60M | |||
| Net Income | -175.00M | -472.00M | -560.10M | 67.90M | 86.50M | |||
| EBITDA | 1.10B | 1.02B | 440.10M | 684.50M | 609.80M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.36 | -0.97 | -1.27 | 0.18 | 0.24 | |||
| Non GAAP EPS | 1.12 | 1.05 | 0.47 | 1.06 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 56.80% | 55.22% | 49.09% | 52.12% | 48.68% | |||
| Profit Margin | -3.77% | -9.91% | -17.11% | 2.21% | 2.82% | |||
| Operating Profit Margin | 8.74% | 6.34% | -2.35% | 12.05% | 10.23% | |||
All data in USD